CEO ups stake in Bulgarian drug maker Sopharma
SOFIA (Bulgaria), January 2 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Thursday that its CEO Ognyan Donev has increased its stake in the company via several transactions on December 30.
Donev acquired 8,600 Sopharma shares at a weighted average price of 3.4051 levs ($1.95/1.74 euro) on December 30, after selling 1,650 shares at a price of 3.3827 levs on December 27, the drug maker said in two filings to the Bulgarian Stock Exchange.
At the end of September, Donev held a stake of below 5% in Sopharma directly, according to the company's most recent interim financial statement.
Indirectly, Donev is the biggest shareholder in Sopharma, as he controls a 25.39% stake through his company Donev Investments Holding. Donev is also a major shareholder in Sopharma's second biggest shareholder - Telecomplect Invest. Telecomplect Invest controls 20.68% interest in Sopharma.
As at 9:30 CET on Thursday, Sopharma shares traded 0.59% higher at 3.42 levs on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)
'Bulgaria Love > 불가리아 뉴스' 카테고리의 다른 글
|Bulgaria's jobless rate edges down to 5.9% at end-Dec (0)||2020.01.16|
|China's Xingyu acquires land for factory construction in Serbia - report (0)||2020.01.16|
|Sofia blue-chip stock index extends winning run backed by Sirma Group, Sopharma (0)||2020.01.13|
|Bulgaria's Sopharma grows 2019 sales 9% (0)||2020.01.13|
|Bulgaria's environment minister resigns (0)||2020.01.13|